Restart Life Sciences (HEAL) Stock Overview

Through its subsidiaries, operates as a biotechnology company worldwide. More details

HEAL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

HEAL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Restart Life Sciences Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Restart Life Sciences
Historical stock prices
Current Share PriceCA$0.10
52 Week HighCA$0.20
52 Week LowCA$0.03
Beta-0.45
1 Month Change33.33%
3 Month Change100.00%
1 Year Change-33.33%
3 Year Change-80.00%
5 Year Change-93.75%
Change since IPO-99.96%

Recent News & Updates

Recent updates

This Is Why Nova Mentis Life Science Corp.'s (CSE:NOVA) CEO Compensation Looks Appropriate

Dec 09
This Is Why Nova Mentis Life Science Corp.'s (CSE:NOVA) CEO Compensation Looks Appropriate

We Think Nova Mentis Life Science (CSE:NOVA) Can Afford To Drive Business Growth

Dec 07
We Think Nova Mentis Life Science (CSE:NOVA) Can Afford To Drive Business Growth

Shareholder Returns

HEALCA BiotechsCA Market
7D25.0%-2.2%0.3%
1Y-33.3%24.7%16.9%

Return vs Industry: HEAL underperformed the Canadian Biotechs industry which returned 24.7% over the past year.

Return vs Market: HEAL underperformed the Canadian Market which returned 16.9% over the past year.

Price Volatility

Is HEAL's price volatile compared to industry and market?
HEAL volatility
HEAL Average Weekly Movementn/a
Biotechs Industry Average Movement9.4%
Market Average Movement8.8%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market3.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine HEAL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aSteve Loutskouwww.restartlife.co

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024.

Restart Life Sciences Corp. Fundamentals Summary

How do Restart Life Sciences's earnings and revenue compare to its market cap?
HEAL fundamental statistics
Market capCA$3.37m
Earnings (TTM)-CA$449.63k
Revenue (TTM)n/a
0.0x
P/S Ratio
-7.5x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HEAL income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$449.63k
Earnings-CA$449.63k

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.013
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did HEAL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/13 07:46
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Restart Life Sciences Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.